Cargando…
How mind-body therapies might reduce pathological features of Alzheimer’s disease
Autores principales: | Hüttenrauch, Melanie, Castro-Obregón, Susana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820700/ https://www.ncbi.nlm.nih.gov/pubmed/35017434 http://dx.doi.org/10.4103/1673-5374.332146 |
Ejemplares similares
-
Intrathecal corticosteroids might slow Alzheimer’s disease progression
por: Alisky, Joseph Martin
Publicado: (2008) -
How Might Cocaine Interfere with Brain Development?
por: Hyman, Steven E
Publicado: (2008) -
Might Fibroblasts from Patients with Alzheimer’s Disease Reflect the Brain Pathology? A Focus on the Increased Phosphorylation of Amyloid Precursor Protein Tyr(682) Residue
por: Iannuzzi, Filomena, et al.
Publicado: (2021) -
How useful are biomarkers for the diagnosis of Alzheimer’s disease and especially for its therapy?
por: Valenza, Marta, et al.
Publicado: (2022) -
Mind the mind: How to effectively communicate about cognition in social–ecological systems research
por: Bercht, Anna Lena, et al.
Publicado: (2018)